Journal of Hepatology
Volume 33, Issue 3 , Pages 376-381 , September 2000

Effects of lipopolysaccharide on TNF-α production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis

  • Jörg Heller

      Affiliations

    • Laboratoire d'Hémodynamique Splanchnique et de Biologie Vasculaire, INSERM U-481France
    • ,
  • Philippe Sogni

      Affiliations

    • Laboratoire d'Hémodynamique Splanchnique et de Biologie Vasculaire, INSERM U-481France
    • ,
  • Eric Barrière

      Affiliations

    • Laboratoire d'Hémodynamique Splanchnique et de Biologie Vasculaire, INSERM U-481France
    • ,
  • Khalid A Tazi

      Affiliations

    • Laboratoire d'Hémodynamique Splanchnique et de Biologie Vasculaire, INSERM U-481France
    • ,
  • Laurence Chauvelot-Moachon

      Affiliations

    • Département de Pharmacologie, Hôpital Cochin, Paris,France
    • ,
  • Marie-Christine Guimont

      Affiliations

    • Service de Biochimie, Hôpital Beaujon, Clichy,France
    • ,
  • Phuong Nhi Bories

      Affiliations

    • Laboratoire de Biochimie, Hôpital Albert Chenevier, Creteil, France
    • ,
  • Odile Poirel

      Affiliations

    • Laboratoire d'Hémodynamique Splanchnique et de Biologie Vasculaire, INSERM U-481France
    • ,
  • Richard Moreau

      Affiliations

    • Laboratoire d'Hémodynamique Splanchnique et de Biologie Vasculaire, INSERM U-481France
    • ,
  • Didier Lebrec

      Affiliations

    • Corresponding Author InformationDidier Lebrec, INSERM U-481, Hôpital Beaujon, F-9118 Clichy, France. Fax: 33 1 47301711.
    • Laboratoire d'Hémodynamique Splanchnique et de Biologie Vasculaire, INSERM U-481France

Received 25 October 1999 ,Revised 19 January 2000 ,Accepted 1 February 2000.

References 

  1. Norton L, Moore G, Eiseman B. Liver failure in the postoperative patient: the role of sepsis and immunologic deficiency. Surgery. 1975;78:6–13
  2. Caly WR, Strauss E. A prospective study of bacterial infection in patients with cirrhosis. J Hepatol. 1993;18:353–358
  3. Llach J, Rimola A, Navasa M, Ginès P, Salmeron JM, Ginès A, et al.  Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration. Hepatology. 1992;16:724–727
  4. Moreau R, Hadengue A, Soupison T, Kirstetter P, Mamzer MF, Vanjak D, et al.  Septic shock in patients with cirrhosis: hemodynamic and metabolic characteristics and intensive care unit outcomes. Crit Care Med. 1992;20:746–750
  5. Baumgartner JD, Vaney C, Perret C. An extreme form of the hyperdynamic syndrome in septic shock. Intensive Care Med. 1984;10:245–249
  6. Groeneveld ABJ, Bronsveld W, Thijs LG. Hemodynamic determinants of mortality in human septic shock. Surgery. 1986;99:140–153
  7. Harry D, Anand R, Holt S, Davies S, Marley R, Fernando B, et al.  Increased sensitivity to endotoxemia in the bile duct-ligated cirrhotic rat. Hepatology. 1999;30:1198–1205
  8. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002–2012
  9. Thiemermann C. Nitric oxide and septic shock. Gen Pharmacol. 1997;29:159–166
  10. Wang JH, Redmond HP, Wu QD, Bouchier-Hayes D. Nitric oxide mediates hepatocyte injury. Am J Physiol. 1998;275:G1117–G1126
  11. Stadler J, Curran RD, Ochoa JB, Harbrecht BG, Hoffmann RA, Simmons RL, et al.  Effect of endogenous nitric oxide on mitochondrial respiration of rat hepatocytes in vitro and in vivo. Arch Surg. 1991;126:186–191
  12. Mustafa SB, Olson MS. Effects of calcium channel antagonists on LPS-induced hepatic iNOS expression. Am J Physiol. 1999;277:G351–G360
  13. Biliar TR, Curran RD, Harbrecht BG, Stuehr DJ, Demetris AJ, Simmons RL. Modulation of nitrogen oxide synthesis in vivo: NG-monomethyl-L-arginine inhibits endotoxin induced nitrate biosynthesis while promoting hepatic damage. J Leukoc Biol. 1990;48:565–569
  14. Guarner C, Soriano G, Tomas A, Bulbena O, Novella MT, Balazo J, et al.  Increased nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology. 1993;18:1139–1143
  15. Campillo B, Bories PN, Benvenuti C, Dupreyon C. Serum and urinary nitrate levels in liver cirrhosis: endotoxemia, renal function and hyperdynamic circulation. J Hepatol. 1996;24:707–714
  16. Heller J, Kristeleit H, Brensing KA, Woitas RP, Spengler U, Sauerbruch T. Nitrite and nitrate levels in patients with cirrhosis of the liver: influence of kidney function and fasting state. Scand J Gastroenterol. 1999;34:297–302
  17. Tilg H, Wilmer A, Vogel W, Herold M, Nolchen B, Judmaier G, et al.  Serum levels of cytokines in chronic liver diseases. Gastroenterology. 1992;103:264–274
  18. Toledo C, Salmerón JM, Rimola A, Navasa M, Arroyo V, Llach J, et al.  Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with ceftaxime. Hepatology. 1993;17:251–257
  19. Lebrec D. Animal models in portal hypertension. In:  Okuda K,  Benhamou JP editor. Portal Hypertension: Clinical and Physiological Aspects. Tokyo: Springer-Verlag; 1991;p. 101–113
  20. Heller J, Sogni P, Tazi KA, Chagneau C, Poirel O, Moreau R, et al.  Abnormal regulation of aortic NOS2 and NOS3 activity and expression from portal vein-stenosed rats after lipopolysaccharide administration. Hepatology. 1999;30:698–704
  21. Boughton-Smith NK, Evans SM, Laszlo F, Whittle BJR. The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br J Pharmacol. 1993;110:1189–1195
  22. Nelson S, Bagby GJ, Bainton BG, Summer WR. The effects of acute and chronic alcoholism on tumor necrosis factor and the inflammatory response. J Inf Dis. 1989;160:422–429
  23. Bories PN, Bories C. Nitrate determination in biological fluids by an enzymatic one-step assay with nitrate reductase. Clin Chem. 1995;41:904–907
  24. Cahill PA, Forster C, Redmond EM, Gingalewski C, Wu Y, Sitzmann JV. Enhanced nitric oxide synthase activity in portal hypertensive rabbits. Hepatology. 1995;22:598–606
  25. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254
  26. Fernandez M, Garcia Pagan JC, Casadevall AM, Bernadich C, Piera C, Whittle BJ, et al.  Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats. Gastroenterology. 1995;108:1487–1490
  27. Heinemann A, Stauber RE. The role of inducible nitric oxide synthase in vascular hyporeactivity of endotoxin-treated and portal hypertensive rats. Eur J Pharmacol. 1995;278:87–90
  28. Sogni P, Smith AP, Gadano A, Lebrec D, Higgenbottam TW. Induction of nitric oxide synthase II does not account for excess vascular nitric oxide production in experimental cirrhosis. J Hepatol. 1997;26:1120–1127
  29. Gadano AC, Sogni P, Heller J, Moreau R, Bories PN, Lebrec D. Vascular nitric oxide production during the development of two experimental models of portal hypertension. J Hepatol. 1999;30:896–903
  30. Rockey DC, Chung JJ. Regulation of inducible nitric oxide synthase and nitric oxide during hepatic injury and fibrogenesis. Am J Physiol. 1997;273:G124–G130
  31. Mizumoto M, Arii S, Furutani M, Nakamura T, Ishigami S, Monden K, et al.  NO as an indicator of portal hemodynamics and the role of iNOS in an increased NO production in CCl4-induced liver cirrhosis. J Surg Res. 1997;70:124–133
  32. Moralez-Ruiz M, Jiménez W, Ros J, Solé M, Leivas A, Bosch-Marcé M, et al.  Nitric oxide production by peritoneal macrophages of cirrhotic rats: a host response against bacterial peritonitis. Gastroenterology. 1997;112:2056–2064
  33. Conn HO, Atterbury CE. Cirrhosis. In:  Schiff L editors. Diseases of the Liver, 6th ed.. Philadelphia: J.B. Lippincott Co; 1987;p. 725–864
  34. Asseury J, Cunha FQ, Liew FY, Moncada S. Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br J Pharmacol. 1993;108:833–837
  35. Griscavage JM, Rogers NE, Sherman MP, Ignarro LJ. Inducible nitric oxide synthase from rat alveolar cell line is inhibited by nitric oxide. J Immunol. 1993;151:6329–6337
  36. Ou J, Carlos TM, Watkins SC, Saavedra JE, Keefer LK, Kim YM, et al.  Differential effects of nonselective nitric oxide synthase (NOS) and selective inducible NOS inhibition on hepatic necrosis, apoptosis, ICAM-1 expression, and neutrophil accumulation during endotoxemia. Nitric Oxide. 1997;1:404–416
  37. Li J, Biliar TR. Nitric oxide IV. Determinants of nitric oxide protection and toxicity in liver. Am J Physiol. 1999;5:G1069–G1073
  38. Beckmann JS, Beckkmann TW, Chen J, Marshall PA, Freemann BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA. 1990;87:1620–1624
  39. Bianchi G, Marchesini G, Fabbri A, Ronchi M, Chianese R, Grossi G. Lipoperoxide plasma levels in patients with liver cirrhosis. Hepatogastroenterol. 1997;44:784–788
  40. Britton RS, Bacon BR. Role of free radicals in liver diseases and hepatic fibrosis. Hepatogastroenterol. 1994;41:343–348
  41. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, et al.  Anti-cachetin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature. 1987;330:662–664
  42. Sarela AI, Mihamaimeed FM, Batten JJ, Davidson BR, Mathie RT. Hepatic and splanchnic nitric oxide activity in patients with cirrhosis. Gut. 1999;44:749–753

PII: S0168-8278(00)80272-X

Journal of Hepatology
Volume 33, Issue 3 , Pages 376-381 , September 2000

Article Tools

* Image Usage & Resolution